[go: up one dir, main page]

MX2018007158A - Uso de compuestos fenolicos derivados de arandano como agente sinergizante antibiotico contra bacterias patogenicas. - Google Patents

Uso de compuestos fenolicos derivados de arandano como agente sinergizante antibiotico contra bacterias patogenicas.

Info

Publication number
MX2018007158A
MX2018007158A MX2018007158A MX2018007158A MX2018007158A MX 2018007158 A MX2018007158 A MX 2018007158A MX 2018007158 A MX2018007158 A MX 2018007158A MX 2018007158 A MX2018007158 A MX 2018007158A MX 2018007158 A MX2018007158 A MX 2018007158A
Authority
MX
Mexico
Prior art keywords
antibiotic
pathogenic bacteria
cranberry
phenolic compounds
agent against
Prior art date
Application number
MX2018007158A
Other languages
English (en)
Inventor
Tufenkji Nathalie
Bharatbhai MAISURIA Vimal
Original Assignee
The Royal Institution For The Advancement Of Learning/Mcgill Univ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Royal Institution For The Advancement Of Learning/Mcgill Univ filed Critical The Royal Institution For The Advancement Of Learning/Mcgill Univ
Publication of MX2018007158A publication Critical patent/MX2018007158A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La presente descripción se refiere al uso de un extracto de arándano rico en proantocianidinas como agente sinergizante antibiótico para mitigar la resistencia a múltiples fármacos y formación de biopelícula en diferentes bacterias patogénicas. La combinación sinérgica del antibiótico y extracto de arándano podría tratar infecciones bacterianas utilizando una dosis más baja de antibióticos para prevenir la formación de biopelícula y la proliferación de microorganismos, con modos de acción definidos.
MX2018007158A 2015-12-11 2016-12-09 Uso de compuestos fenolicos derivados de arandano como agente sinergizante antibiotico contra bacterias patogenicas. MX2018007158A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562266334P 2015-12-11 2015-12-11
US201662366666P 2016-07-26 2016-07-26
PCT/CA2016/051447 WO2017096484A1 (en) 2015-12-11 2016-12-09 Use of cranberry derived phenolic compounds as antibiotic synergizing agent against pathogenic bacteria

Publications (1)

Publication Number Publication Date
MX2018007158A true MX2018007158A (es) 2019-01-10

Family

ID=59012453

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018007158A MX2018007158A (es) 2015-12-11 2016-12-09 Uso de compuestos fenolicos derivados de arandano como agente sinergizante antibiotico contra bacterias patogenicas.

Country Status (5)

Country Link
US (1) US20180360898A1 (es)
EP (1) EP3386526B1 (es)
CA (1) CA3046254C (es)
MX (1) MX2018007158A (es)
WO (1) WO2017096484A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018183369A1 (en) * 2017-03-27 2018-10-04 Rhode Island Council On Postsecondary Education Cranberry-derived compositions for potentiating antibiotic efficacy against bacterial persistence
DE102018127408A1 (de) * 2018-11-02 2020-05-07 Ruhrpharm AG Cranberry-Extrakt-PAC-A-Zusammensetzung und dessen Verwendung bei der Prävention und/oder Behandlung von Harnwegsinfekten
CN109479907A (zh) * 2018-11-30 2019-03-19 福建农林大学 一种天然细菌群体感应抑制剂的制备方法
CN115844944A (zh) * 2022-12-27 2023-03-28 遵义医科大学 血人参提取物在制备氨基糖苷类抗生素抗铜绿假单胞菌增敏剂中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070166409A1 (en) * 2006-01-17 2007-07-19 Royds Robert B Therapeutic compositions containing trimethoprim and cranberry extract and methods for treating and preventing urinary tract infections
WO2010078660A1 (en) * 2009-01-12 2010-07-15 The Royal Institution For The Advancement Of Learning/Mcgill University Use of proanthocyanidins as an anti-apoptotic agent and anti-adhesive bacterial agent
FR2949197B1 (fr) * 2009-08-21 2012-08-03 Loic Renard Composition alimentaire antibacterienne

Also Published As

Publication number Publication date
EP3386526A4 (en) 2019-07-31
EP3386526B1 (en) 2024-11-13
EP3386526A1 (en) 2018-10-17
WO2017096484A1 (en) 2017-06-15
CA3046254C (en) 2023-11-07
US20180360898A1 (en) 2018-12-20
CA3046254A1 (en) 2017-06-15
EP3386526C0 (en) 2024-11-13

Similar Documents

Publication Publication Date Title
MX2016009898A (es) Tratamientos para acne resistente.
MX2018001075A (es) Agentes terapeuticos y profilacticos antibacterianos.
CL2018003425A1 (es) Composiciones de cannabidiol y usos de las mismas.
CL2015003120A1 (es) Cepas bacterianas que poseen actividad antimicrobiana y composiciones de control biológico que las contienen
CL2016002992A1 (es) Combinación, composición y método de administración de la combinación o composición a animales
GT201600183A (es) Compuestos orgánicos de monobactam para el tratamiento de infecciones bacterianas
CL2015002755A1 (es) Composiciones antibióticas de ceftolozano.
ECSP19073204A (es) Mitorriboscinas: compuestos terapéuticos basados en mitocondrias que fijan como objetivo células cancerosas, bacterias y levaduras patógenas
CL2012002902A1 (es) Cepas de bacteriofagos especifica contra bacterias pertenecientes al genero vibrio para la profilaxis y terapia de vibrio anguillarum; y composicion antibacteriana que comprende dicha cepas.
MX363678B (es) Terapia de combinación que comprende oxazolidinona-quinolonas para usarse en el tratamiento de infecciones bacterianas.
MX2018007158A (es) Uso de compuestos fenolicos derivados de arandano como agente sinergizante antibiotico contra bacterias patogenicas.
CL2012003266A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas; composicion farmacéutica y/o dermocosmética antimicrobiana que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo ; metodo para tratar y/o prevenir a un paciente que tiene una infeccion microbiana.
MX376475B (es) Derivado de polimixina y usos del mismo.
MX393266B (es) Composiciónpara usarse en terapia de microbiota
BR112017020796A2 (pt) compostos, composição farmacêutica e kit
CL2019001918A1 (es) Métodos para tratar infecciones bacterianas.
MX387476B (es) Antibióticos de amplio espectro macrocíclico.
HK1243951A1 (zh) 抗微生物组合和其在治疗微生物感染中的用途
CL2017001276A1 (es) Derivados de benzotiazol antibacterianos
BR112018014723A2 (pt) fantasmas bacterianos para o tratamento de câncer
BR112016018048A2 (pt) Método para o tratamento ou prevenção de uma infecção bacteriana, uso de um inibidor de topoisomerase tipo ii bacteriana em combinação com uma polimixina ou derivado de polimixina no tratamento ou prevenção de uma infecção bacteriana, uso de um inibidor de topoisomerase tipo ii bacteriana em combinação com uma polimixina ou derivado de polimixina na preparação de um medicamento para o tratamento ou prevenção de uma infecção bacteriana, método para melhorar a atividade antibacteriana de um inibidor de topoisomerase tipo ii bacteriana, método para melhorar a eficácia bactericida de um inibidor de topoisomerase tipo ii bacteriana, composição, agente antibacteriano, processo, e, composto
IN2013MU03216A (es)
PL386175A1 (pl) Nowe szczepy bakteriofagów do leczenia zakażeń bakteryjnych, zwłaszcza szczepami bakterii lekoopornych rodzaju Enterococcus
CL2017001818A1 (es) Bacteria de ácido láctico y su uso para el tratamiento de mastitis
PL425327A1 (pl) Zastosowanie α,β,2',3'-tetrahydroksantohumolu